1
|
Cardiogenic shock due to left main related myocardial infarction: is revascularization enough? J Geriatr Cardiol 2022; 19:152-157. [PMID: 35317397 PMCID: PMC8915424 DOI: 10.11909/j.issn.1671-5411.2022.02.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
2
|
Shibata N, Umemoto N, Tanaka A, Takagi K, Iwama M, Uemura Y, Inoue Y, Negishi Y, Ohashi T, Tanaka M, Yoshida R, Shimizu K, Tashiro H, Yoshioka N, Morishima I, Noda T, Watarai M, Asano H, Tanaka T, Tatami Y, Takada Y, Ishii H, Murohara T. Clinical Outcomes Following Emergent Percutaneous Coronary Intervention for Acute Total/Subtotal Occlusion of the Left Main Coronary Artery. Circ J 2021; 85:1789-1796. [PMID: 33746154 DOI: 10.1253/circj.cj-20-0545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
BACKGROUND Data regarding the clinical features, outcomes and prognostic factors in patients presenting with acute total/subtotal occlusion of the unprotected left main coronary artery (LMCA) remain limited.Methods and Results:From a multi-center registry, 134 patients due to acute total/subtotal occlusion of the unprotected LMCA were reviewed. Emergency room (ER) status classification was defined according to the presence of cardiogenic shock and cardiopulmonary arrest (CPA) in the ER (class 1=no cardiogenic shock; class 2= cardiogenic shock but not CPA; and class 3=CPA). In-hospital mortality and cerebral performance category (CPC) as the endpoints were evaluated. One-half (67/134) of the enrolled patients presented with total occlusion of the unprotected LMCA. Regarding ER status classification, class 1, 2, and 3 were observed in 30.6%, 45.5%, and 23.9% of the patients, respectively. In-hospital mortality occurred in 73 (54.5%) patients; of the remaining patients, 52 (85.3%) could be discharged with a CPC 1 or 2. ER status classification (odds ratio 4.4 [95% confidence interval: 2.33-10.67]; P<0.001) and total occlusion of the unprotected LMCA (odds ratio 8.29 [95% confidence interval 2.93-23.46]; P<0.001) were strong predictors of in-hospital mortality. CONCLUSIONS Acute total/subtotal occlusion involving the unprotected LMCA appeared to be associated with high in-hospital mortality. ER status classification and initial flow in the unprotected LMCA were significant predictive factors of in-hospital mortality.
Collapse
Affiliation(s)
- Naoki Shibata
- Department of Cardiology, Ichinomiya Municipal Hospital.,Department of Cardiology, Nagoya University Graduate School of Medicine
| | - Norio Umemoto
- Department of Cardiology, Ichinomiya Municipal Hospital
| | - Akihito Tanaka
- Department of Cardiology, Nagoya University Graduate School of Medicine
| | | | - Makoto Iwama
- Department of Cardiology, Gifu Prefectural General Medical Center
| | | | - Yosuke Inoue
- Department of Cardiology, Tosei General Hospital
| | | | | | - Miho Tanaka
- Department of Cardiology, Konan Kosei Hospital
| | - Ruka Yoshida
- Department of Cardiology, Nagoya University Graduate School of Medicine.,Department of Cardiology, Japanese Red Cross Society Nagoya Daini Hospital
| | | | - Hiroshi Tashiro
- Department of Cardiology, Nagoya University Graduate School of Medicine
| | | | | | - Toshiyuki Noda
- Department of Cardiology, Gifu Prefectural General Medical Center
| | | | | | | | | | | | - Hideki Ishii
- Department of Cardiology, Nagoya University Graduate School of Medicine.,Department of Cardiology, Fujita Health University Bantane Hospital
| | - Toyoaki Murohara
- Department of Cardiology, Nagoya University Graduate School of Medicine
| | | |
Collapse
|
3
|
Shu Y, Ye P, Zhang J, Chang Z. Design of equipment for preparing drug-eluting stents with single-sided coating. Technol Health Care 2020; 28:67-76. [PMID: 31156186 DOI: 10.3233/thc-181532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND Drug-eluting stent technology has rapidly developed in recent years. In particular, stents are used in percutaneous coronary intervention (PCI), which has become a vital method in clinic treatment. Although various methods are currently used to prepare drug-eluting stents, these methods are associated with respective limitations. OBJECTIVE To design equipment for preparing drug-eluting stents with single-sided coating and to precisely accomplish the drug-coating process for a single side. METHODS This coating equipment prepared stents in three stages: the precise displacement and translational motion and rotational motion of the operating platform; the recognition and positioning of the stent strut; and the utilisation of a pL-scale inkjet system. In order to control and synchronise the work of each subsystem, a central processing unit was installed. RESULTS Through the analysis and solutions of various problems occurring in the experiment, the spraying equipment was improved, and its functions were perfected. Thus, the successful operation of the spraying equipment was realised. CONCLUSIONS The design of the equipment introduced in this article meets the requirements for preparing drug-eluting stents.
Collapse
Affiliation(s)
- Yuting Shu
- Shanghai Institute for Minimally Invasive Therapy, School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China
| | - Ping Ye
- Shanghai Institute for Minimally Invasive Therapy, School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China
| | - Jie Zhang
- Shanghai Institute for Minimally Invasive Therapy, School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.,Shanghai Microport Medical (Group) Co., Ltd, Shanghai 201203, China
| | - Zhaohua Chang
- Shanghai Institute for Minimally Invasive Therapy, School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.,Shanghai Microport Medical (Group) Co., Ltd, Shanghai 201203, China
| |
Collapse
|
4
|
Pepe M, Biondi-Zoccai G, Corcione N, Nestola PL, Ferraro P, Morello A, Conte S, Prati F, Bianchi FP, Bortone AS, Giordano A. Comparative Effectiveness and Safety of Polymer-Free Biolimus-Eluting Stent and Durable Polymer Everolimus-Eluting Stent in All-Comer Patients Who Underwent Percutaneous Coronary Interventions. Am J Cardiol 2019; 124:195-204. [PMID: 31103132 DOI: 10.1016/j.amjcard.2019.04.015] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/22/2019] [Revised: 03/30/2019] [Accepted: 04/04/2019] [Indexed: 02/08/2023]
Abstract
We aim to compare Polymer-Free Biolimus-Eluting Stent (PF-BES) with Durable Polymer Everolimus-Eluting stent (DP-EES) in unselected patients. PF-BES showed a favorable profile in high-bleeding risk patients who underwent percutaneous coronary intervention. Limited data are available on PF-BES compared with second-generation durable polymer-coated drug-eluting stents in patients eligible for standard dual antiplatelet therapy. A total of 848 consecutive patients were enrolled: 306 patients were treated with PF-BES and 542 with DP-EES. Stent performance was tested in a propensity score-matched population and in a Complex Higher-Risk and Indicated Patients (CHIP) subpopulation. A per-lesion analysis on 1,204 lesions (PF-BES = 424 vs DP-EES = 780) was also performed. At a medium follow-up of 18.5 ± 5.0 months, no differences in the matched population were found in terms of major adverse cardiac events (PF-BES 9.0% vs DP-EES 4.5%; p 0.091), myocardial infarction (PF-BES 6.2% vs DP-EES 2.3%; p 0.111), stent restenosis (PF-BES 2.3% vs DP-EES 0.0%; p 0.123), definite or probable stent thrombosis (PF-BES 2.8% vs DP-EES 1.1%; p 0.448). A significant inferior rate of restenosis was observed in the DP-EES arm in the whole (PF-BES 2.3% vs DP-EES 0.6%; p 0.041) and CHIP populations (PF-BES 4.3% vs DP-EES 0.5%; p 0.023), as well as in the per-lesion analysis (DP-EES 0.4% vs PF-BES 1.7%; p 0.039). In conclusion, in a real-world cohort PF-BES performed similarly to DP-EES in terms of restenosis and stent thrombosis in the matched population. Nonetheless, in the whole and CHIP populations, as well as in the per-lesion analysis, restenosis occurrence resulted higher in the PF-BES group.
Collapse
|
5
|
Abstract
Cardiogenic shock (CS) is a state of critical end-organ hypoperfusion primarily due to cardiac dysfunction. This condition is the most common cause of death in patients affected by acute myocardial infarction (AMI). Despite early revascularization, prompt optimal medical therapy, and up-to-date mechanical circulatory supports, mortality of patients with CS remains high.The objective of this review is to summarize epidemiology, pathophysiology, and treatment options of CS in light of the new European Society of Cardiology (ESC) recommendations. The latest European guidelines on myocardial revascularization have reviewed the previous guidelines with respect to early multivessel revascularization and routine use of intra-aortic balloon pump (IABP) in patients with AMI-related CS.Most of the current evidences come partly from randomized trials, but mostly from observational registries because of the difficulty to test different treatments in this life-threatening clinical setting.Some of the latest studies highlight the potential crucial benefit of newly introduced mechanical circulatory support devices, although evidences are not sufficient to definitely assess the benefit/risk ratio of the different systems.Many questions remain unanswered in this field, and further trials are advocated to better elucidate the best medical, reperfusion, and circulatory support approaches aimed to improve the poor prognosis of patients with CS after AMI.
Collapse
|
6
|
Wang Y, Cheng YS, Yin XQ, Yu G, Jia BL. Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway. Am J Physiol Cell Physiol 2018; 316:C223-C234. [PMID: 30462534 DOI: 10.1152/ajpcell.00242.2018] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Insulin resistance (IR) continues to pose a major threat to public health due to its role in the pathogenesis of metabolic syndrome and its ever-increasing prevalence on a global scale. The aim of the current study was to investigate the efficacy of Anxa2 in obesity-induced IR through the mediation of the NF-κB signaling pathway. Microarray analysis was performed to screen differentially expressed genes associated with obesity. To verify whether Anxa2 was differentially expressed in IR triggered by obesity, IR mouse models were established in connection with a high-fat diet (HFD). In the mouse IR model, the role of differentially expressed Anxa2 in glycometabolism and IR was subsequently detected. To investigate the effect of Anxa2 on IR and its correlation with inflammation, a palmitic acid (PA)-induced IR cell model was established, with the relationship between Anxa2 and the NF-κB signaling pathway investigated accordingly. Anxa2 was determined to be highly expressed in IR. Silencing Anxa2 was shown to inhibit IR triggered by obesity. When Anxa2 was knocked down, elevated expression of phosphorylated insulin receptor substrate 1 (IRS1), IRS1 and peroxisome proliferator-activated receptor coactivator-1a, and glucose tolerance and insulin sensitivity along with 2-deoxy-d-glucose uptake was detected, whereas decreased expression of suppressor of cytokine signaling 3, IL-6, IL-1β, TNF-α, and p50 was observed. Taken together, the current study ultimately demonstrated that Anxa2 may be a novel drug strategy for IR disruption, indicating that Anxa2 gene silencing is capable of alleviating PA or HFD-induced IR and inflammation through its negative regulatory role in the process of p50 nuclear translocation of the NF-κB signaling pathway.
Collapse
Affiliation(s)
- Yong Wang
- Department of Gastrointestinal Surgery, the Second Hospital of Anhui Medical University , Hefei , People's Republic of China
| | - Yun-Sheng Cheng
- Department of Gastrointestinal Surgery, the Second Hospital of Anhui Medical University , Hefei , People's Republic of China
| | - Xiao-Qiang Yin
- Department of Gastrointestinal Surgery, the Second Hospital of Anhui Medical University , Hefei , People's Republic of China
| | - Gang Yu
- Department of Gastrointestinal Surgery, the Second Hospital of Anhui Medical University , Hefei , People's Republic of China
| | - Ben-Li Jia
- Department of Gastrointestinal Surgery, the Second Hospital of Anhui Medical University , Hefei , People's Republic of China
| |
Collapse
|
7
|
Liu HW, Han YL, Jin QM, Wang XZ, Ma YY, Wang G, Wang B, Xu K, Li Y, Chen SL. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention. Chin Med J (Engl) 2018; 131:1412-1419. [PMID: 29893357 PMCID: PMC6006809 DOI: 10.4103/0366-6999.233948] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
Background Very few data have been reported for ST-segment elevation myocardial infarction (STEMI) caused by unprotected left main coronary artery (ULMCA) occlusion, and very little is known about the results of this subgroup of patients who underwent primary percutaneous coronary intervention (PCI). The aim of this study was to determine the clinical features and outcomes of patients with STEMI who underwent primary PCI for acute ULMCA occlusion. Methods From January 2000 to February 2014, 372 patients with STEMI caused by ULMCA acute occlusion (ULMCA-STEMI) who underwent primary PCI at one of two centers were enrolled. The 230 patients with non-ST-segment elevation MI (NSTEMI) caused by ULMCA lesion (ULMCA-NSTEMI) who underwent emergency PCI were designated the control group. The main indexes were the major adverse cardiac events (MACEs) in-hospital, at 1 month, and at 1 year. Results Compared to the NSTEMI patients, the patients with STEMI had significantly higher rates of Killip class≥III (21.2% vs. 3.5%, χ2 = 36.253, P < 0.001) and cardiac arrest (8.3% vs. 3.5%, χ2 = 5.529, P = 0.019). For both groups, the proportions of one-year cardiac death in the patients with a post-procedure thrombolysis in myocardial infarction (TIMI) flow grade<3 were significantly higher than those in the patients with a TIMI flow grade of 3 (STEMI group: 51.7% [15/29] vs. 4.1% [14/343], P < 0.001; NSTEMI group: 33.3% [3/9] vs. 13.6% [3/221], P = 0.001; respectively]. Landmark analysis showed that the patients in STEMI group were associated with higher risks of MACE (16.7% vs. 9.1%, P = 0.009) and cardiac death (5.4% vs. 1.3%, P = 0.011) compared with NSTEMI patients at 1 month. Meanwhile, in patients with ULMCA, the landmark analysis for incidences of MACE and cardiac death was similar between the STEMI and NSTEMI (all P = 0.72) in the intervals of 1-12 months. However, patients who were diagnosed with STEMI or NSTEMI had no significant difference in reinfarction (all P > 0.05) and TVR (all P > 0.05) in the intervals of 0-1 month as well as 1 month to 1 year. The results of Cox regression analysis showed that the differences in the independent predictors for MACE included the variables of Killip class ≥ III and intra-aortic balloon pump support for the STEMI patients and the variables of previous MI, ULMCA distal bifurcation, and 2-stent for distal ULMCA lesions for the NSTEMI patients. Conclusions Compared to the NSTEMI patients, the patients with STEMI and ULMCA lesions still remain at a much higher risk for adverse events at 1 year, especially on 1 month. If a successful PCI procedure is performed, the 1-year outcomes in those patients might improve.
Collapse
Affiliation(s)
- Hai-Wei Liu
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Ya-Ling Han
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Quan-Min Jin
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Xiao-Zeng Wang
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Ying-Yan Ma
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Geng Wang
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Bin Wang
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Kai Xu
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Yi Li
- Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning 110016, China
| | - Shao-Liang Chen
- Department of Cardiology, Nanjing First Hospital, Nanjing, Jiangsu 210006, China
| |
Collapse
|
8
|
Pepe M, Cafaro A, Paradies V, Signore N, Addabbo F, Bortone AS, Navarese EP, Contegiacomo G, Forleo C, Bartolomucci F, Di Cillo O, Bianchi FP, Zanna D, Favale S. Time‐dependent benefits of pre‐treatment with new oral P2Y
12
‐inhibitors in patients addressed to primary PCI for acute ST‐elevation myocardial infarction. Catheter Cardiovasc Interv 2018; 93:592-601. [DOI: 10.1002/ccd.27863] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2018] [Revised: 08/02/2018] [Accepted: 08/12/2018] [Indexed: 11/06/2022]
Affiliation(s)
- Martino Pepe
- Division of Cardiology, Department of Emergency and Organ TransplantationUniversity of Bari Bari Italy
| | - Alessandro Cafaro
- Cardiovascular DepartmentF. Miulli Hospital Acquaviva delle Fonti Italy
| | - Valeria Paradies
- Department of CardiologyMaasstad Ziekenhuis Hospital Rotterdam Netherlands
| | - Nicola Signore
- Division of CardiologyAzienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari Italy
| | - Francesco Addabbo
- Department of Biomedical Sciences & Human OncologyUniversity of Bari Medical School Bari Italy
| | - Alessandro Santo Bortone
- Division of Heart Surgery, Department of Emergency and Organ TransplantationUniversity of Bari Bari Italy
| | - Eliano Pio Navarese
- Inova Heart and Vascular Institute Falls Church Virginia
- Interventional Cardiology and Cardiovascular Research, Mater Dei Hospital Bari Italy
| | - Gaetano Contegiacomo
- Interventional Cardiology and Cardiovascular ResearchMater Dei Hospital Bari Italy
| | - Cinzia Forleo
- Division of Cardiology, Department of Emergency and Organ TransplantationUniversity of Bari Bari Italy
| | | | - Ottavio Di Cillo
- Chest Pain Unit, Cardiology EmergencyUniversity of Bari Bari Italy
| | | | - Domenico Zanna
- Division of Cardiology, Department of Emergency and Organ TransplantationUniversity of Bari Bari Italy
| | - Stefano Favale
- Division of Cardiology, Department of Emergency and Organ TransplantationUniversity of Bari Bari Italy
| |
Collapse
|
9
|
Pepe M, Zanna D, Cafaro A, Marchese A, Addabbo F, Navarese EP, Napodano M, Cecere A, Resta F, Paradies V, Bortone AS, Favale S. Role of plasma glucose level on myocardial perfusion in ST-segment elevation myocardial infarction patients. J Diabetes Complications 2018; 32:764-769. [PMID: 29937139 DOI: 10.1016/j.jdiacomp.2018.05.015] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/17/2017] [Revised: 05/18/2018] [Accepted: 05/19/2018] [Indexed: 01/08/2023]
Abstract
AIMS Hyperglycemia is frequent in patients with ST elevation myocardial infarction (STEMI) and is associated with adverse outcome. Aim of our study was to evaluate the correlation between admission plasma glucose level (PGL) and coronary arteries flow velocity. METHODS We enrolled 149 STEMI patients successfully treated with primary percutaneous coronary intervention (pPCI). The study population was divided into two groups based on PGL (< or >140 mg/dl) and on history of diabetes, and the groups compared in terms of corrected TIMI frame count (cTFC). RESULTS Hyperglycemic patients had a significantly higher cTFC in both the culprit (p < 0.0001) and non-culprit vessel (p: 0.0002); diabetes history impairs as well cTFC of the culprit (p < 0.0001) and non-culprit vessel (p: 0.0001). Within the subpopulation of diabetic patients hyperglycemic ones showed higher cTFC in both the culprit (p 0.0013) and non-culprit vessel (p: 0.0006). Moreover in the whole population cTFC values of both arteries increase linearly with the increment of admission PGL. CONCLUSIONS Admission PGL affects coronary flow of both culprit and non-culprit vessel. The impairment of coronary flow is also demonstrated in known diabetic patients, suggesting to consider hyperglycemia an additional risk factor. We finally demonstrated for the first time a positive linear relationship between PGL and cTFC.
Collapse
Affiliation(s)
- Martino Pepe
- Cardiovascular Diseases Section, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy
| | - Domenico Zanna
- Cardiovascular Diseases Section, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy
| | - Alessandro Cafaro
- Department of Cardiology, General Hospital "F. Miulli", Acquaviva delle Fonti, Bari, Italy
| | - Alfredo Marchese
- Department of Cardiology, Anthea Hospital, GVM Care & Research, Bari, Italy
| | - Francesco Addabbo
- Department of Biomedical Sciences & Human Oncology, University of Bari Medical School, Bari, Italy
| | - Eliano Pio Navarese
- Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University, Düsseldorf, Germany
| | - Massimo Napodano
- Department of Cardiac, Thoracic and Vascular Sciences, Hospital-University of Padova, Padova, Italy
| | - Annagrazia Cecere
- Cardiovascular Diseases Section, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy.
| | - Fabrizio Resta
- Department of Cardiology, "Santa Maria" Hospital, GVM Care & Research, Bari, Italy
| | - Valeria Paradies
- Department of Cardiology, Maasstad Ziekenhuis Hospital, Rotterdam, Netherlands
| | - Alessandro Santo Bortone
- Division of Heart Surgery, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy
| | - Stefano Favale
- Cardiovascular Diseases Section, Department of Emergency and Organ Transplantation (DETO), University of Bari, Bari, Italy
| |
Collapse
|
10
|
Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents. Coron Artery Dis 2016; 27:535-42. [DOI: 10.1097/mca.0000000000000396] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
11
|
Renal insufficiency and left main coronary artery disease: reconsidering coronary intervention and bypass surgery. Coron Artery Dis 2016; 27:529-31. [PMID: 27681273 DOI: 10.1097/mca.0000000000000410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
12
|
Uretsky BF, Mathew J, Ahmed Z, Hakeem A. Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm. Catheter Cardiovasc Interv 2015; 87:90-100. [DOI: 10.1002/ccd.26034] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/02/2015] [Revised: 04/24/2015] [Accepted: 05/07/2015] [Indexed: 11/08/2022]
Affiliation(s)
- Barry F. Uretsky
- Cardiology Division; University of Arkansas for Medical Sciences, Central Arkansas Veterans Health System; Little Rock Arkansas
| | - Jacob Mathew
- Cardiology Division; University of Arkansas for Medical Sciences, Central Arkansas Veterans Health System; Little Rock Arkansas
| | - Zubair Ahmed
- Cardiology Division; University of Arkansas for Medical Sciences, Central Arkansas Veterans Health System; Little Rock Arkansas
| | - Abdul Hakeem
- Cardiology Division; University of Arkansas for Medical Sciences, Central Arkansas Veterans Health System; Little Rock Arkansas
| |
Collapse
|
13
|
Park SM, Ahn CM, Hong SJ, Kim YH, Park JH, Shim WJ, Lim DS. Acute changes of left ventricular hemodynamics and function during percutaneous coronary intervention in patients with unprotected left main coronary artery disease. Heart Vessels 2014; 30:432-40. [DOI: 10.1007/s00380-014-0495-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2013] [Accepted: 02/28/2014] [Indexed: 11/30/2022]
|
14
|
Vis MM, Beijk MA, Grundeken MJ, Baan J, Koch KT, Wykrzykowska JJ, Arkenbout EK, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP. A Systematic Review and Meta-Analysis on Primary Percutaneous Coronary Intervention of an Unprotected Left Main Coronary Artery Culprit Lesion in the Setting of Acute Myocardial Infarction. JACC Cardiovasc Interv 2013; 6:317-24. [DOI: 10.1016/j.jcin.2012.10.020] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2012] [Revised: 09/04/2012] [Accepted: 10/11/2012] [Indexed: 10/27/2022]
|
15
|
Long-term changes in neointimal hyperplasia following implantation of bare metal stents assessed by integrated backscatter intravascular ultrasound. Heart Vessels 2012; 28:415-23. [DOI: 10.1007/s00380-012-0266-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2011] [Accepted: 05/25/2012] [Indexed: 10/28/2022]
|
16
|
Bauer T, Möllmann H, Zeymer U, Hochadel M, Nef H, Weidinger F, Zahn R, Hamm CW, Marco J, Gitt AK. Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry. Heart Vessels 2011; 27:453-9. [DOI: 10.1007/s00380-011-0207-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2011] [Accepted: 07/08/2011] [Indexed: 11/30/2022]
|
17
|
Dardas PS, Mezilis N, Ninios V, Tsikaderis D, Theofilogiannakos EK. The use of the GuideLiner™ catheter as a child-in-mother technique: an initial single-center experience. Heart Vessels 2011; 27:535-40. [DOI: 10.1007/s00380-011-0181-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2011] [Accepted: 07/22/2011] [Indexed: 10/17/2022]
|